Further analysis on the subgroup of patients who were treated with endocrine therapy alone revealed that SLC1A5 protein expression remained a predictive marker for high risk of breast cancer death (P = 0.03), (Supplementary Table 2). This evidence concerns the gene SLC1A5 and breast cancer.